Preview Mode Links will not work in preview mode

Mad in America: Rethinking Mental Health


The Mad in America podcast, hosted by James Moore, examines mental health with a critical eye by speaking with psychologists, psychiatrists and people with lived experience.

When you hear such conversations, you realise that much of what is believed to be settled in mental health is actually up for debate. Is mental health a matter of faulty biology or is there more to it? Are the treatments used in psychiatry helpful or harmful in the long term? Are psychiatric diagnoses reliable? With the help of our guests, we examine these questions and so much more. 

This podcast is part of Mad in America’s mission to serve as a catalyst for rethinking psychiatric care and mental health. We believe that the current drug-based paradigm of care has failed our society and that scientific research, as well as the lived experience of those who have been diagnosed with a psychiatric disorder, calls for profound change. 

On the podcast over the coming weeks, we will have interviews with experts and those with lived experience of the psychiatric system. Thank you for joining us as we discuss the many issues around rethinking mental health around the world.

For more information visit madinamerica.com

 

Nov 16, 2022

On the Mad in America podcast this wweek we are joined by renowned psychopharmacologist Dr David Healy.

David is a psychiatrist, scientist and author. Before becoming a professor of Psychiatry in Wales, and more recently in the Department of Family Medicine at McMaster University in Canada, he studied medicine in Dublin and at Cambridge University.

He is a former Secretary of the British Association for Psychopharmacology, and has authored more than 220 peer-reviewed articles, 300 other pieces, and 25 books, including The Antidepressant Era, The Creation of Psychopharmacology and Pharmageddon.

He has been involved as an expert witness in homicide and suicide trials involving psychotropic drugs, and in bringing problems with these drugs to the attention of American and European regulators, as well raising awareness of how pharmaceutical companies sell drugs by marketing diseases and co-opting academic opinion-leaders, ghost-writing their articles.

David is a founder and CEO of Data Based Medicine Limited, which operates through its website RxISK.org, dedicated to making medicines safer through online direct patient reporting of drug side effects.

In this interview we discuss the recently held World Tapering Day, a possible relationship between antidepressant treatment and sensory neuropathy and the difficulties that can be encountered when trying to deprescribe.